Gerald Svedlow
Internal Medicine · Santa Barbara, CANPI 1255365292
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 166 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,284 and has fallen 98.7% since, to $17 in 2022.
Across 166 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$548
- AstraZeneca$435
- Novo Nordisk$351
- Pfizer$272
- AbbVie$215
- Portola Pharmaceuticals, LLC$200
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,072100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 30 | $548 |
| AstraZeneca | 21 | $435 |
| Novo Nordisk | 24 | $351 |
| Pfizer | 14 | $272 |
| AbbVie(2 entities) | 17 | $215 |
| Portola Pharmaceuticals, LLC | 7 | $200 |
| Amarin Pharma, Inc. | 8 | $165 |
| Nestle Healthcare Nutrition Inc. | 5 | $90 |
| Boehringer Ingelheim | 4 | $90 |
| GSK | 4 | $85 |
| Astellas Pharma US Inc | 3 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| Eisai Inc. | 3 | $54 |
| Lilly USA, LLC | 3 | $45 |
| Dexcom, Inc. | 1 | $45 |
| Merck | 2 | $38 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Nabriva Therapeutics, PLC | 2 | $27 |
| Amgen | 1 | $26 |
| Paratek Pharmaceuticals, Inc. | 1 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Almatica Pharma LLC | 1 | $20 |
| IBSA Pharma Inc. | 1 | $19 |
| Genentech USA, Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Companion Medical, Inc. | 1 | $17 |
| Mannkind Corporation | 1 | $15 |
| Therapeuticsmd, Inc. | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$115
How this compares
$3,072 in reported general payments places this provider in the 85th percentile of 13,581 internal medicine providers in California.
Other internal medicine in Santa Barbara
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
- Hatim HusainSan Diego$2M
- Teck LingPalo Alto$1.1M
- Hyong Kimla Jolla$1M
- Rohit Loombala Jolla$965K
- Fred CohenSan Francisco$929K
- Steven EdelmanSan Diego$863K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.